School of Public Health, The University of Adelaide, Level 9, AHMS Building, North Terrace, Adelaide, SA, 5005, Australia.
Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia.
Diabetologia. 2020 Jun;63(6):1162-1173. doi: 10.1007/s00125-020-05111-w. Epub 2020 Feb 24.
AIMS/HYPOTHESIS: Evidence of an association between maternal smoking during pregnancy (prenatal smoking) and childhood type 1 diabetes is mixed. Previous studies have been small and potentially biased due to unmeasured confounding. The objectives of this study were to estimate the association between prenatal smoking and childhood type 1 diabetes, assess residual confounding with a negative control design and an E-value analysis, and summarise published effect estimates from a meta-analysis.
This whole-of-population study (births from 1999 to 2013, participants aged ≤15 years) used de-identified linked administrative data from the South Australian Early Childhood Data Project. Type 1 diabetes was diagnosed in 557 children (ICD, tenth edition, Australian Modification [ICD-10-AM] codes: E10, E101-E109) during hospitalisation (2001-2014). Families not given financial assistance for school fees was a negative control outcome. Adjusted Cox proportional HRs were calculated. Analyses were conducted on complete-case (n = 264,542, type 1 diabetes = 442) and imputed (n = 286,058, type 1 diabetes = 557) data. A random-effects meta-analysis was used to summarise the effects of prenatal smoking on type 1 diabetes.
Compared with non-smokers, children exposed to maternal smoking only in the first or second half of pregnancy had a 6% higher type 1 diabetes incidence (adjusted HR 1.06 [95% CI 0.73, 1.55]). Type 1 diabetes incidence was 24% lower (adjusted HR 0.76 [95% CI 0.58, 0.99]) among children exposed to consistent prenatal smoking, and 16% lower for exposure to any maternal smoking in pregnancy (adjusted HR 0.84 [95% CI 0.67, 1.08]), compared with the unexposed group. Meta-analytic estimates showed 28-29% lower risk of type 1 diabetes among children exposed to prenatal smoking compared with those not exposed. The negative control outcome analysis indicated residual confounding in the prenatal smoking and type 1 diabetes association. E-value analysis indicated that unmeasured confounding associated with prenatal smoking and childhood type 1 diabetes, with a HR of 1.67, could negate the observed effect.
CONCLUSIONS/INTERPRETATION: Our best estimate from the study is that maternal smoking in pregnancy was associated with 16% lower childhood type 1 diabetes incidence, and some of this effect was due to residual confounding.
目的/假设:孕妇吸烟(产前吸烟)与儿童 1 型糖尿病之间关联的证据参差不齐。先前的研究由于存在未测量的混杂因素而规模较小且可能存在偏倚。本研究的目的是估计产前吸烟与儿童 1 型糖尿病之间的关联,通过负对照设计和 E 值分析评估残留混杂,并对荟萃分析中发表的效应估计进行总结。
这项全人群研究(1999 年至 2013 年出生,参与者年龄≤15 岁)使用了南澳大利亚幼儿数据项目的去识别链接行政数据。557 名儿童(ICD,第十版,澳大利亚修正版[ICD-10-AM]代码:E10、E101-E109)在住院期间被诊断患有 1 型糖尿病(2001-2014 年)。家庭未获得学费资助是一个负对照结局。计算了调整后的 Cox 比例 HR。对完整病例(n=264542,1 型糖尿病=n=442)和推断病例(n=286058,1 型糖尿病=n=557)数据进行了分析。使用随机效应荟萃分析总结产前吸烟对 1 型糖尿病的影响。
与不吸烟者相比,仅在妊娠前半段或后半段暴露于母亲吸烟的儿童 1 型糖尿病发病率高 6%(调整后的 HR 1.06 [95%CI 0.73, 1.55])。在持续暴露于产前吸烟的儿童中,1 型糖尿病发病率降低 24%(调整后的 HR 0.76 [95%CI 0.58, 0.99]),而在怀孕期间暴露于任何母亲吸烟的儿童中,发病率降低 16%(调整后的 HR 0.84 [95%CI 0.67, 1.08]),与未暴露组相比。荟萃分析估计表明,与未暴露于产前吸烟的儿童相比,暴露于产前吸烟的儿童患 1 型糖尿病的风险降低 28-29%。负对照结局分析表明,产前吸烟与 1 型糖尿病之间的关联存在残留混杂。E 值分析表明,与儿童 1 型糖尿病相关的未测量混杂因素,HR 为 1.67,可能会否定观察到的效应。
结论/解释:我们从研究中得出的最佳估计是,母亲在怀孕期间吸烟与儿童 1 型糖尿病发病率降低 16%有关,而这种影响的一部分是由于残留混杂。